drugset / Trial / NCT01289431
Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis
RandomizedParallel-groupDouble-blindPrevention
Summary
The objective of this study is to evaluate the dose response, and efficacy of Mapracorat ophthalmic formulation compared to its vehicle for the prevention of symptoms and signs associated with allergic conjunctivitis using a conjunctival allergen challenge (CAC) model.
Timeline
- Start
- 2011-02
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mapracorat | Small molecule | — | Other |